MindSpectrum

MindSpectrum is a web-based platform offering free, confidential autism spectrum screening using three clinically recognized instruments: the Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R), the Autism Spectrum Quotient (AQ), and the Camouflaging Autistic Traits Questionnaire (CAT-Q). The platform positions itself as a privacy-first starting point for individuals exploring neurodiversity, providing self-assessment tools that can be completed from home without registration or payment.

According to the vendor, the assessments are backed by scientific research and designed to help users understand their traits before seeking formal clinical evaluation. The platform falls within the broader Healthcare category of AI-assisted and digital health tools.

What the Platform Offers

The core experience centers on completing one or more validated screening questionnaires. After finishing an assessment, users receive a detailed downloadable report that includes a score breakdown for each instrument. These reports are intended to provide language and structured data that individuals can share with therapists, doctors, or other healthcare professionals. Testimonials featured on the homepage describe users bringing their results to therapy sessions and using the report to articulate experiences they previously struggled to explain.

For those whose results indicate significant autistic traits, the platform provides a structured set of recommended next steps: save and document the results, download the detailed report, and consult a qualified professional for further evaluation.

Privacy and Accessibility

The platform emphasizes a privacy-first design. Assessments are conducted confidentially, and the vendor states that no payment is required at any stage. The privacy framing appears to address a common barrier to seeking autism evaluation — the fear of judgment or exposure — and testimonials cited on the site reinforce this value proposition.

Developer and Provider API

MindSpectrum also documents a provider-facing API, described as offering REST and webhook coverage. The API is currently in pre-release, with the vendor inviting interested parties to request access. Planned capabilities include automated project provisioning, management of branded templates, and render triggering from external applications. Webhook previews are intended to deliver real-time status updates to integrated systems.

API documentation directories exist in Simplified Chinese, Japanese, and Korean, suggesting the platform is building for multilingual clinical environments, particularly in East Asian markets.

Limitations to Consider

All available evidence in the source packet consists of vendor claims and curated testimonials. The clinical validity of the screening instruments — while well-established in the research literature for RAADS-R, AQ, and CAT-Q independently — is not independently verified within the platform's own materials. The API remains in pre-release, meaning its documented capabilities cannot be confirmed as operational. Several test pages display only loading states, suggesting the product catalog may be under active development.

Self-report screening tools, regardless of their research pedigree, are not substitutes for professional diagnosis. The platform itself acknowledges this by directing users with elevated scores toward clinical consultation. Similar tools in the online autism screening space include Omogle and Dr7.ai, each offering different assessment instruments and feature sets.